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Abstract:  In the present study, we compared the cell damage response in skeletal and cardiac muscle tissue when
exposed to doxorubicin.  This was carried out by means of a less invasive informative substitute to endomyocardiac
biopsy based on Hsp70 immunodetection and a subcellular analysis of the nucleolus.  Male Sprague Dawley rats (62 g
body weight) were randomly distributed into 3 group, the control and doxorubicin I and doxorubicin II groups, in which
15 and 25 mg/kg body weight of doxorubicin (0.1 ml, i.v.) was administered, respectively.  After 15, 30, 45 and 60
minutes, portions of the left and right ventricle wall and interventricle wall, together with skeletal muscle from the
posterior and anterior member, were prepared for Hsp70 immunodetection by Western blot analysis and ultrastructural
study using the thin cut technique.  Differential cell response between the control and treated groups was observed in
Hsp70 immunodetection and at the subcellular level.  In the control group, the Hsp70 recognition levels and typical
normal nucleolar morphology were similar, while the treated groups showed variable-dependent Hsp70 recognition and
segregation of nucleolar components, forming ring-like figures of a variable-independent nature.  Comparison of cardiac
and skeletal muscle tissue cell response to doxorubicin toxic aggression revealed parallelism in terms of Hsp70
accumulation in certain regions of both tissues (15 mg/kg body weight of doxorubicin), which suggests that replacing
endomyocardiac biopsy analysis with skeletal muscle analysis may be a safe option.  (J Toxicol Pathol 2009; 22: 273–
279)
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Introduction
Clinical use of anthracyclines can be viewed as a sort of
double-edged sword.  The anthracyclines, including
doxorubicin (DOX), play an undisputed, key role in the
treatment of many neoplastic diseases, but they also cause
cardiotoxicity and/or introduce a measurable risk of delayed
cardiovascular events1–3.  In addition, the ultrastructural
features of anthracyc1ine-induced cardiomyopathy,
evidenced in patients’ endomyocardial biopsies, are also
seen in mice, rats and rabbits treated with the drug,
indicating the existence of species-independent morphologic
damage4.  Despite the side effects, DOX is considered
irreplaceable and as a result is widely employed5,6.
Currently, the most common method used to detect
anthracycline-induced cardiotoxicity is evaluation of
functional parameters, including the left ventricular ejection
fraction and fractional shortening by echocardiography7.
However, serious, irreversible heart damage must occur for
these tests to be considered abnormal8.  In this regard,
detection of anthracycline-induced cardiotoxicity at an early
stage is still disputed.  Endomyocardial biopsy (EMB)
remains the golden standard with which to assess and
diagnose myocardial disease in patients9.  However, its
invasive characteristic, given the clinical importance of
myocardiac damage caused by DOX, represents an
additional element of aggression for the pathological cardiac
condition, which limits its usefulness10.  Given the risks of
using EMB, it is necessary to seek a less invasive alternative
or one that is non-invasive, safe, accurate, informative and
predictive with respect to the cardiac condition and yet
capable of preserving antineoplasic effectiveness.  The
similarity between heart and skeletal muscle at the
ultrastructural level after DOX treatment has previously
been pointed out by Meski et al.11 Moreover, the stress-
dependent changes in nucleolar reorganization are
associated with cell response to the proteotoxic damage
resulting from elevated expression of heat-shock proteins
(Hsps) that function as molecular chaperones and maintain
vital homeostasis of the protein folds.  In this regard, when
subjected to stress there is a tissue-specific Hsp70 response
in animals12.  The differential expression of Hsp70 and
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ultrastructural features in heart and liver rat tissue after
short-term DOX treatment have previously been shown13,
which means that they can now be used as comparative
indicators of the degree of susceptibility in tissue submitted
to similar toxic aggression.  On the other hand, a reduction of
Hsp70 expression in rat cardiac muscle after chronic DOX
treatment has been demonstrated14.  In this work, we
investigated the Hsp stress response in cardiac and skeletal
tissue induced by DOX toxic aggression.  Principally, we
examined the expression of Hsp70 in the right and left
ventricular free walls, interventricular septum and anterior
and posterior skeletal limb muscle plus the changes in
nucleolar reorganization of all regions at two DOX dosages
and four different post-treatment times.  Cardiac, versus
skeletal, tissue cell response to DOX toxic aggression
reveals parallelism in terms of Hsp70 expression and the
relationship to nucleolar reorganization.  In this regard,
substitution of one tissue for another based upon cellular
similarity stress response would be advantageous since it
could prevent additional damage to the heart, while
providing information about cell response to antineoplastic
treatment.  Skeletal muscle biopsy represents a possible
informative substitute for EMB in DOX cardiomyopathy.
Methods
Animals
Male Sprague Dawley rats (body weight 62 ± 5 g; 3–4
weeks of age) were acquired from the Instituto Venezolano
de Investigaciones Científicas (Caracas, Venezuela).  The
rats were allowed free access to a standard diet and water ad
libitum.  This investigation complied with the norms set out
in the Guide for the Care and Use of Laboratory Animals
published by the US National Institutes of Health (NIH
publication No. 85–23, revised 1996) and related ethical
regulations of the Universidad Central de Venezuela ,
Instituto de Medicina Tropical.
Materials
DOX, monoclonal anti-heat shock protein 70 (Hsp70,
clone BRM-22) and anti-mouse IgG peroxidase conjugate
were obtained from Sigma-Aldrich (St. Louis, MO, USA).
Chemiluminescent substrate from Pierce Biotechnology
(Rockford, IL, USA).  Bio-Rad Laboratories (Hercules, CA,
USA) was the source of all other biochemical compounds.
The components used in the ultrastructural study were
obtained from Electron Microscopy Sciences (Hatfield, PA,
USA).
DOX administration protocol
Rats were randomly distributed into three groups (12
each): Control group (CON), Doxorubicin I (DOX-I) and
Doxorubicin II (DOX-II).  DOX was administered in single
doses of 15 or 25 mg/kg (0.1 ml, i.v.) body weight,
respectively.  The selection of DOX dosage was base on
unpublished data from a previous study in our laboratory of
LD100, which is defined as the lethal dose required to cause
death in 100% of rats within 24 and 48 hours.  The CON
group rats received sterile water (0.1 ml; i.v.).  After 15, 30,
45 and 60 minutes post-treatment of the animals (3 each), the
left and right ventricular and interventricular walls (LV, RV
and IV, respectively) and posterior (medial head of
gastronemius) and anterior (extensor carpi ulnaris) member
skeletal muscle (PM and AM, respectively) were removed
for subsequent analysis.
Ultrastructural analysis
The samples from both muscle tissues were fixed with
Karnovsky’s fixative (320 mosmol, pH 7.4, for 2 h, at 4°C),
post-fixed in osmic acid (osmium tetroxide, 2% 0.12 M 2 h
4°C 320 mosmol, pH 7.4) dissolved in phosphate buffer (l h
at room temperature) and dehydrated in acetone (50%, 70%,
80%, 95% and 100%; 30 min each).  Finally, they were
embedded in epoxy resin (60°C, 48 h).  After embedding,
thin sections were cut (Reichert OM-U3 ultramicrotome),
stained with saturated uranyl acetate (45 min, 60°C, moist
chamber) and lead citrate (15 min, room temperature, dry
chamber) and examined with a transmission electron
microscope (Hitachi 300, 70 kvol).
Western blot analysis
The samples from both muscle tissues were
homogenised (4°C; 1 ml extraction buffer composed of 20
mM Tris-HCL, 2 mM EDTA and 1mM PMSF, pH 7.4) using
a Potter-Elvehjem tissue grinder.  The samples were
centrifuged (14.000 RPM/10 min, 4°C), and the pellet was
discarded.  The protein content in the resulting supernatants
was determined by Bradford microassay15 using albumin as
a standard.  Equal amount of proteins (3.6 μg) diluted in a 4×
SDS sample buffer (10 mM tris-HCL, pH 6.8; 1% SDS, 1%
2-β-mercaptoethanol, 1% glycerol, a small amount of
bromophenol blue and pyronin) were separated on 10%
polyacrylamide gels by SDS-PAGE16 in duplicated gels.
One of the gels was stained with Coomassie Brilliant Blue
G-250 to confirm the equivalence of the loading
concentrations and adequacy of sample preparation, while a
second gel was transferred to a nitrocellulose membrane and
stained with Ponceau Red before inmunobloting17.
Nonspecific binding sites of the membranes were blocked
(0.1% Tween 20 and 5% non-fat milk in PBS, pH 7.4),
incubated with the primary monoclonal anti-Hsp70 antibody
(1:5000) and then incubated with the secondary horseradish
peroxidase-conjugated-rabbit anti mouse IgG antibody
(1:4000).  The washes were performed with 0.1% Tween 20
in PBS (pH 7.4).  Inmunoreactive bands were revealed by a
chemoluminescent substrate and exposed to Kodak X-ray
film for 2 minutes.  The relative levels of the protein bands
were determined using an optical densitometry (GS-800
Densitometer and Quantity One software, Bio-Rad
Laboratories).
Statistical analysis
Data are expressed as means ± SEM of at least threeMaita, Strauss, Anselmi 275
independent experiments.  Non-normal distribution,
Kruskal-Wallis and Mann-Whitney U tests were used.  All
tests performed were two-sided, and statistical significance
was defined as P<0.05.  All statistical analyses were
performed using SPSS Statistics for Windows 17.0 (SPSS,
Inc., Chicago, IL, USA).
Results
Ultrastructural analyses
A concentric accumulation of macromolecules in
random distribution, typical of a cell under normal
conditions, was observed in the nucleolus of both muscle
types from the CON group, where a region of nucleolar
organisation (RNO) and a dense fibril and granular
component (DFC and GC, respectively; Fig. 1) were
identified.  In contrast, in the DOX-I and DOX-II groups, a
tendency towards segregation of components or compact
nucleolar structures was observed for all DOX post-
treatment times (Figs. 2, 3).  In the nucleoli of cardiac tissue
(A–D, Figs. 1, 2) and skeletal muscle tissue (E–H, Figs. 1,
2), the segregation was characterised principally by a ring-
like configuration, with a less electron-dense element in a
central or lateral location (Fig. 2, A–D, E, H; Fig. 3, A–D, F).
The compact nucleolar structures evidenced a tight grouping
of electron-dense elements in a spherical shape, in which an
accumulation of less electron-dense elements, often towards
the periphery, could also be observed (Fig. 2, F–G; Fig. 3, E,
G, H).
Hsp70 immunodetection
Hsp70 recognition in the CON group was similar in the
LV, RV, IV and PM, but was slightly less in the AM (Figs.
4, 5).  In contrast, in the DOX-I group, two similar patterns
of Hsp70 recognition were evident among the regions and
tissues.  One pattern, in the LV, RV and PM, was related to
greater Hsp70 recognition, while the other in the IV and AM,
was related to lesser Hsp70 recognition.  The difference
between these two patterns was statistically significant
(p<0.05, Kruskal-Wallis and Mann-Whitney U test).  In
addition, greater recognition was also evidenced in all
muscle zones.  Recognition was greater at 45 min compared
with 15 and 60 min, respectively.  At 30 min, recognition
was noticeably less (Figs. 4, 5).
This differential recognition was statistically significant
(p<0.05, Kruskal-Wallis and Mann-Whitney U test).
Compared with the DOX-II group, tissue and time-
independent Hsp70 recognition was clearly evidenced in a
uniform zone, similar to the CON group, although detection
in the latter was slightly greater.  Differential Hsp70
recognition was only observed at 60 min and was
characterized as being greater in the LV and IV than in the
RV, AM and PM (p<0.05, Kruskal-Wallis and Mann-
Whitney U test, Figs. 4, 5). 
Discussion
The similarity in nucleolar alterations observed in the
two types of tissue exposed to DOX corresponds to the
Fig. 1. Transmission electron micrographs of a cardiac muscle (A) and skeletal muscle cells (B) from the control group.
Characteristic central and peripheral positions of the nuclelus and a typical distribution of nucleolar components (inset)
was observed Nuclei (N), Nucleolus (n), nucleolar organisation region (white arrow head) and the granular component
(black arrow head). Myofibrils (MF), mitochondria (m) and the perinuclear chromatin (C) were also revealed. Scale bars:
1 μm (Figs. 1A, 1B) and 0.12 μm (insets, taken at 75 kV).276 Alternative Doxorubicin Cardiac Damage Evaluation
Fig. 2. Transmission electron micrograph of cardiac muscle and skeletal muscle cell nucleoli with respect to different post-treatment times of a
low dose of doxorubicin (DOX-I group: 15 mg/kg bw). The reorganisation of nucleolar components showed segregation of nucleolar
components (A–D, E, H) and compact nucleorar structures (F–G). Cardiac muscle cells (A–D), skeletal muscle cells (E–H). Post-
treatment times (in minutes): 15 (A, E), 30 (B, F), 45 (C, G), 60 (D, H). Nucleolar organisation region (white arrow head), dense fibrilar
component (arrow), granular component (black arrow head);  myofibrils (MF), mitochondria (m) and perinuclear chromatin (C). Scale
bar: 0.12 μm, taken at 75 kV.
Fig. 3. Transmission electron micrograph of cardiac muscle and skeletal muscle cell nucleoli with respect to different post-treatment times of a
high dose of doxorubicin (DOX-II group: 25 mg/kg bw). The reorganisation of nucleolar components showed segregation for nucleolar
components (B–D, F, H), and compact nucleorar structures (A, G) were observed in all post-treatment times. Cardiac muscle cells (A–D),
skeletal muscle cells (E–H). Post-treatment times (in minutes): 15 (A, E), 30 (B, F), 45 (C, G), 60 (D, H). Nucleolar organisation region
(white arrow head), dense fibrilar component (arrow), granular component (black arrow head), and perinuclear chromatin (C). Scale bar:
0.12 μm, taken at 75 kV.Maita, Strauss, Anselmi 277
findings of Merski et al. who showed the tissue-dependent
nature of the event11.  This nucleolar alteration has been
identified as the morphological biomarker of cell damage18–
20 and has been linked to the process of translocation and
subsequent accumulation of members of the Hsp70 family in
the nucleus as a result of stress21, 22.  All the members of this
family recognized by the anti-Hsp70 monoclonal mouse
antibody are made up of isoforms.  Under normal conditions,
they are expressed constitutively, such as Hsp73 and the
stress-inducible isoform Hsp72, which constitute important
stress proteins located in the cytosol and nucleus of the cells
of mammals.  In this respect, the parallelism in recognition
of Hsp70 bands observed in all the muscle zones
investigated in the CON groups reflects the similarity in the
content of constitutive isoforms under normal conditions.
This presence under normal conditions may represent the
starting point from which the cell is equipped with the
capacity to respond rapidly to adverse conditions.  In the
DOX-I group, the zone-tissue dependent differential pattern
of Hsp70 recognition for all the post-treatment times in the
present study seems to be associated with different
susceptibility.  The susceptibility can be related to the
differential expression of Hsps in function of the role of the
tissues in restoration of protein homeostasis23.
This differential response in Hsp70 recognition can
only occur within the interval of homeostatic cell
adaptability, during which there is certain proportionality
between the degree of toxic damage and the capacity of cell
response24.
During this interval, the characteristic zone and tissue
differences predominate among the range of endogenous cell
protection mechanisms in the specific tissue space.  These
differences in terms of the intrinsic characteristics of cell
Fig. 4. Western blot analysis of Hsp 70 from the cardiac and skeletal
muscle tissue of the CON and DOX groups at the post-
administration times. Similar Hsp70 recognition between the
LV, RV, IV and PM, slightly less recognition in the AM,
were observed in the CON group. A greater amount of Hsp70
was recognized in the LV, RV and PM in the DOX-I group
compared with the IV and AM, for all post-treatment times.
In the DOX-II group, tissue and time independent Hsp70
recognition were observed in a uniform region for all time
points except 60 min, with recognition in the LV and IV
greater compared with the RV, AM and PM. A: Control
group (sterile water: 0.1 ml; i.v). B: DOX-I group (15 mg/kg
bw). C: DOX-II group (25 mg/kg bw. Post-treatment times
(in minutes): 15, 30, 45 and 60. Tissues regions: left (LV) and
right ventricular (RV) and interventricular walls (IV) and
posterior (PM) and anterior member skeletal muscle (protein
μg per lane: 3.6 μg).
Fig. 5. Densitometric analysis of the relative levels of Hsp70 accumulation in the cardiac and skeletal tissue regions in the DOX I (A: 15 mg/kg
bw) and DOX II (B: 25 mg/kg bw) groups compared with the CON (sterile water, 0.1 ml i.v.) group for the different post-treatment times
(in minutes). In CON group, the accumulation of Hsp70 was similar in the LV, RV, IV and PM, with recognition slightly less in the AM.
By contrast, in the DOX I group, the relative levels of Hsp70 accumulation in the LV, RV and PM were greater than in the IV and AM for
all post-treatment times; in the DOX-II group, the relative levels of Hsp70 accumulation were uniform in all regions and for all post-
treatment times, except at 60 min, at which the levels were greater in the LV and IV compared with the RV, AM and PM. Tissues regions:
left (LV), right ventricular (RV) and interventricular walls (IV) and posterior (PM) and anterior (AM) member skeletal muscle. Data are
means ± S.E. of 3 animals in each group. P<0.05.278 Alternative Doxorubicin Cardiac Damage Evaluation
types, which were outlined by Beck et al., are what
determine the expression of heat shock genes, rather than
specific physiological or environmental conditions25.  One
example of the specificity of zonal susceptibility associated
with a particular tissue can be found in the work of Strauss et
al., who showed a substantial reduction in the thickness of
the left ventricle wall compared with the right wall after
eight and twelve weeks post-DOX-treatment26.  Besides this,
the work of Oishi et al.27 also showed a differential response
of Hsps to heat stress in slow and fast regions of rat
gastrocnemius muscle.  In general, the expression of Hsp70
was reduced in both the cardiac and skeletal muscles
regardless of the region after DOX treatment.
Since Hsp expression varies from one cell type to
another, this tissue-dependent differential pattern in Hsp
recognition suggests an apparent similarity between the LV,
RV and PM on the one hand and between IV and AM on the
other, in regard to cell response to toxic damage generated
by the sub-lethal dosage in the DOX-I group.  This pattern of
similarity would in turn justify our proposal for substituting
endomyocardiac biopsies with skeletal muscle biopsies.  In
contrast, the uniformity in the Hsp70 recongnition in the
DOX-II group with respect to the distinct muscle zones
analyzed for the two types of tissue could be accounted for
by the displacement of cellular response capacity to the
limits of the homeostatic adaptability interval23, where cell
response tends to be linear.  This dosage-dependency in
Hsp70 recognition in the muscle zones and time periods
analysed is in line with previous findings showing that the
magnitude, type and duration of response depends on the
degree of damage generated by the toxic aggression, with the
maximum response corresponding to the point at which Hsps
are synthesized to a maximum extent28.  The lack of an exact
correspondence between the levels of cellular organization
analyzed can be explained in terms of the findings reported
by De Haans29, who argued that cellular differences that are
not detected at a morphological level can be identified or
highlighted at the molecular level.  Finally, the apparent
similarity found between the cardiac and skeletal muscle
should continue to be evaluated in regard to the possibility of
substituting endomyocardiac biopsies for skeletal muscle
analyses within the interval of homeostatic cell adaptability
in response to DOX toxic aggression.
Comparison of cardiac and skeletal muscle tissue cell
response to DOX toxic aggression revealed explicit
similarity in terms of Hsp70 accumulation in certain regions
of both tissues, which suggests that the possibility of
replacing endomyocardiac biopsy analysis with skeletal
muscle analysis may be a safe option. 
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